3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
55
Ovarian Neoplasms
39
Carcinoma, Hepatocellular
39
Neoplasms
25
Fallopian Tube Neoplasms
21
Carcinoma, Non-Small-Cell Lung
20
Endometrial Neoplasms
14
Glioblastoma
11
Breast Neoplasms
11
Brain Neoplasms
11
Colonic Neoplasms
10
Neoplasm Metastasis
9
Lung Neoplasms
8
Liver Neoplasms
8
Uterine Cervical Neoplasms
7
Stomach Neoplasms
6
Rectal Neoplasms
6
Glioma
6
Biliary Tract Neoplasms
6
Carcinoma, Ovarian Epithelial
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Parkinson Disease 4, Autosomal Dominant Lewy Body
4
Small Cell Lung Carcinoma
3
Sarcoma
3
Recurrence
3
Peritoneal Neoplasms
3
Pancreatic Neoplasms
3
Neoplasms, Nerve Tissue
3
Gastrointestinal Neoplasms
3
Interventions
Cisplatin
14
Paclitaxel
12
pembrolizumab
9
Fluorouracil
7
Radiotherapy
6
Irinotecan
5
Esophagectomy
5
tislelizumab
4
Oxaliplatin
4
Leucovorin
4
Drug Therapy
4
Carboplatin
4
toripalimab
3
Levoleucovorin
3
Docetaxel
3
Capecitabine
3
camrelizumab
2
Taxes
2
Radiation
2
Nivolumab
2
Injections
2
130-nm albumin-bound paclitaxel
2
spartalizumab
1
sintilimab
1
palbociclib
1
nimotuzumab
1
nazartinib
1
lenvatinib
1
ivarmacitinib
1
futibatinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
Bevacizumab
×
90 days
×
Clear all
No trials found.